APA

Bouvin-Pley M., Morgand M., Meyer L., Goujard C., Moreau A., Mouquet H., Nussenzweig M., Pace C., Ho D., Bjorkman P. J., Baty D., Chames P., Pancera M., Kwong P. D., Poignard P., Barin F. & Braibant M. (20150218). Drift of the HIV-1 envelope glycoprotein gp120 toward increased neutralization resistance over the course of the epidemic: a comprehensive study using the most potent and broadly neutralizing monoclonal antibodies. : Journal of virology.

Chicago

Bouvin-Pley M, Morgand M, Meyer L, Goujard C, Moreau A, Mouquet H, Nussenzweig M, Pace C, Ho D, Bjorkman P J, Baty D, Chames P, Pancera M, Kwong P D, Poignard P, Barin F and Braibant M. 20150218. Drift of the HIV-1 envelope glycoprotein gp120 toward increased neutralization resistance over the course of the epidemic: a comprehensive study using the most potent and broadly neutralizing monoclonal antibodies. : Journal of virology.

Harvard

Bouvin-Pley M., Morgand M., Meyer L., Goujard C., Moreau A., Mouquet H., Nussenzweig M., Pace C., Ho D., Bjorkman P. J., Baty D., Chames P., Pancera M., Kwong P. D., Poignard P., Barin F. and Braibant M. (20150218). Drift of the HIV-1 envelope glycoprotein gp120 toward increased neutralization resistance over the course of the epidemic: a comprehensive study using the most potent and broadly neutralizing monoclonal antibodies. : Journal of virology.

MLA

Bouvin-Pley M, Morgand M, Meyer L, Goujard C, Moreau A, Mouquet H, Nussenzweig M, Pace C, Ho D, Bjorkman P J, Baty D, Chames P, Pancera M, Kwong P D, Poignard P, Barin F and Braibant M. Drift of the HIV-1 envelope glycoprotein gp120 toward increased neutralization resistance over the course of the epidemic: a comprehensive study using the most potent and broadly neutralizing monoclonal antibodies. : Journal of virology. 20150218.